This retrospective study aims to analyze the efficacy and safety of PD-1 inhibitors combined with albumin-bound paclitaxel and cisplatin in the treatment of recurrent or metastatic hypopharyngeal/laryngeal squamous cell carcinoma. Here, ALB is linked to laryngeal squamous cell carcinoma.